Global trends in breast cancer incidence and mortality 1973-1997, Int J Epidemiol, vol.34, pp.405-417, 2005. ,
, Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials, Lancet, vol.352, pp.930-972, 1998.
, Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials, Lancet, vol.351, pp.1451-67, 1998.
HER-2/neu amplification predicts poor survival in node-positive breast cancer, Cancer Res, vol.50, pp.4332-4339, 1990. ,
Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer, Invest New Drugs, vol.23, pp.391-409, 2005. ,
Untangling the ErbB signalling network, Nat Rev Mol Cell Biol, vol.2, pp.127-164, 2001. ,
Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF, Int J Cancer, vol.100, pp.2-8, 2002. ,
New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades, Oncogene, vol.20, pp.1532-1541, 2001. ,
G-protein-coupled receptors and signaling networks: emerging paradigms, Trends Pharmacol Sci, vol.22, pp.368-76, 2001. ,
Neuropeptides as growth factors for normal and cancerous cells, Trends Endocrinol Metab, vol.13, pp.128-162, 2002. ,
Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues, Endocr Rev, vol.24, pp.571-99, 2003. ,
Neurotensin counteracts apoptosis in breast cancer cells, Biochem Biophys Res Commun, vol.295, pp.482-490, 2002. ,
Neurotensin receptor 1 gene activation by the Tcf/ h-catenin pathway is an early event in human colonic adenomas, Carcinogenesis, vol.27, pp.708-724, 2006. ,
Neurotensin: peptide for the next millennium, Regul Pept, vol.93, pp.125-161, 2000. ,
Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor, Proc Natl Acad Sci, vol.90, pp.65-74, 1993. ,
Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone, Prog Histochem Cytochem, vol.16, pp.1-172, 1985. ,
Plasma cholecystokinin and neurotensin after an ordinary meal in humans. A prolonged time study717, Gastroenterol Clin Biol, vol.22, pp.25-33, 1998. ,
Effect of neurotensin on exocrine pancreatic secretion in dogs, Digestion, vol.23, pp.174-83, 1982. ,
Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin, Acta Physiol Scand, vol.100, pp.231-236, 1977. ,
Neurotensin stimulates [3H]oleic acid translocation across rat small intestine, Am J Physiol, vol.251, pp.823-832, 1986. ,
Relevant genomics of neurotensin receptor in cancer, Anticancer Res, vol.20, pp.53-61, 2000. ,
Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease, Clin Cancer Res, vol.6, pp.566-71, 2000. ,
Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPasemediated NF-nB pathways, Am J Physiol Cell Physiol, vol.284, pp.1397-404, 2003. ,
Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells, Eur J Pharmacol, vol.442, pp.179-86, 2002. ,
Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2, Biochem Biophys Res Commun, vol.269, pp.704-712, 2000. ,
Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells, Regul Pept, vol.120, pp.155-66, 2004. ,
Metalloproteinasedependent transforming growth factor-a release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells, J Biol Chem, vol.279, pp.43547-54, 2004. ,
Progestin effect on cell proliferation and 17h-hydroxysteroid dehydrogenase activity in normal human breast cells in culture, J Clin Endocrinol Metab, vol.63, pp.1174-80, 1986. ,
Histological grading and prognosis in breast cancer, Br J Cancer, vol.3, pp.359-77, 1957. ,
Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms, J Biol Chem, vol.272, pp.10087-94, 1997. ,
URL : https://hal.archives-ouvertes.fr/inserm-02459623
Collagen invasion assay, Cancer invasion and metastasis, pp.81-90, 2000. ,
Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer, Lab Invest, vol.77, pp.345-55, 1997. ,
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in nodenegative patients, Br J Cancer, vol.84, pp.1488-96, 2001. ,
Matrix metalloproteinases in tumor invasion: role for cell migration, Pathol Int, vol.52, pp.255-64, 2002. ,
The discovery of anthranilic acid-based MMP inhibitors. Part 3. Incorporation of basic amines, Bioorg Med Chem Lett, vol.11, pp.2975-2983, 2001. ,
Wnt signaling and breast cancer, Cancer Biol Ther, vol.3, pp.36-41, 2004. ,
Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation, J Biol Chem, vol.279, pp.12636-12682, 2004. ,
Fetal and neoplastic expression of the neurotensin gene in the human colon, Ann Surg, vol.223, pp.464-70, 1996. ,
Serum peptide profiles in patients with carcinoid tumors, Am J Surg, vol.186, pp.28-31, 2003. ,
Neurotensinlike immunoreactivity in plasma and tumor tissue from patients with endocrine tumors of the pancreas and gut, Gastroenterology, vol.85, pp.881-890, 1983. ,
Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers, Am J Physiol Gastrointest Liver Physiol, vol.279, pp.1139-1186, 2000. ,
Endocrine gene neurotensin: molecular mechanisms and a model of intestinal differentiation, World J Surg, vol.26, pp.799-805, 2002. ,
Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms, J Neurosci, vol.18, pp.6672-80, 1998. ,
Postprandial levels of prolactin and gut hormones in breast cancer patients: association with stage of disease, but not dietary fat, J Natl Cancer Inst, vol.82, pp.22-31, 1990. ,
Identification of genes associated with enhanced metastasis of a large cell lung carcinoma cell line, Anticancer Res, vol.23, pp.187-94, 2003. ,
SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells, Peptides, vol.22, pp.109-124, 2001. ,
Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes, J Biol Chem, vol.276, pp.44464-71, 2001. ,
Src-mediated activation of the human neurotensin/neuromedin N promoter, Surgery, vol.122, pp.180-185, 1997. ,
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis, Clin Cancer Res, vol.10, pp.7621-7629, 2004. ,
,